Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 68071-5183 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 5183 3
This is a pharmaceutical label belonging to NuCare Pharmaceuticals, Inc. The label contains information about Losartan Potassium 100mg, a medication used for high blood pressure. It shows details such as product code (P2026030), manufacturer's NDC (0054-022), lot number (000000), and expiration date (00-00). The label also warns users to keep the medication away from children and store it at a controlled temperature. Patients are advised to consult a doctor for medical advice.*
fig1.jpg - fig1
The text refers to two medications, Atenolol and Losartan, and mentions an adjusted risk reduction of 13% with a p-value of 0.021. It also includes a chart with study months and the percentage of patients with the primary endpoint. It seems to be a report or analysis of a clinical study comparing the effectiveness of these two drugs.*
fig2.jpg - fig2
The text appears to be a graph showing the percentage of patients with fatal or non-fatal stroke over a period of time. The graph includes two lines labeled "Atenolol" and "Losartan". It is not possible to determine the exact percentages or other specific details from the given text.*
fig3.jpg - fig3
This text appears to be a table showing the results of a study comparing the rates of a primary composite stroke event in patients taking Losartan and Atenolol. The table includes data on the number of events and hazard ratios for different patient subgroups based on age, gender, race, ISH, diabetes and history of CVD.*
fig4.jpg - fig4
This is a chart showing the comparison between the effectiveness of Losartan and Placebo in reducing the risk by 16.1%. The chart displays some numerical values, but there is not enough context to describe the purpose or source of the data.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.